IFP Advisors’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-250
Closed 3925
2018
Q4
$0 Hold
250
﹤0.01% 4111
2018
Q3
$0 Hold
250
﹤0.01% 4174
2018
Q2
$1K Hold
250
﹤0.01% 3844
2018
Q1
$1K Hold
250
﹤0.01% 3728
2017
Q4
$1K Sell
250
-52
-17% -$144 ﹤0.01% 3779
2017
Q3
$1K Hold
302
﹤0.01% 4037
2017
Q2
$1K Sell
302
-125
-29% -$544 ﹤0.01% 4036
2017
Q1
$2K Hold
427
﹤0.01% 3751
2016
Q4
$1K Sell
427
-50
-10% -$181 ﹤0.01% 3935
2016
Q3
$3K Hold
477
﹤0.01% 3530
2016
Q2
$2K Buy
+477
New +$3.11K ﹤0.01% 3561
2016
Q1
Sell
-352
Closed -$10K 4153
2015
Q4
$10K Buy
+352
New +$10.6K ﹤0.01% 2608

IFP Advisors's PTX Position: Q1 2019 in Review

IFP Advisors sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q1 2019, closing a stake of 250 shares.

IFP Advisors first reported a position in PTX in Q4 2015 and held it in 12 quarters. The position peaked at $10K in Q4 2015. 1 fund tracked by Wall St. Rank holds PTX as of Q1 2019.

  • IFP Advisors reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q1 2019 after selling out during the quarter.
  • IFP Advisors sold 250 Pernix Therapeutics Holdings, Inc. shares in Q1 2019.
  • IFP Advisors first reported a position in Pernix Therapeutics Holdings, Inc. in Q4 2015 and held it in 12 quarters.
  • IFP Advisors's Pernix Therapeutics Holdings, Inc. position peaked at $10K in Q4 2015.
  • 1 fund tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2019.

Based on IFP Advisors's 13F filing for Q1 2019, filed 15 May 2019.